Court rejects PhRMA’s challenge to Medicare drug price negotiations
The U.S. Court of Appeals for the Fifth Circuit affirmed a lower court’s ruling in favor of HHS and CMS on Aug. 26, upholding the Medicare Drug Price Negotiation Program against a constitutional challenge from PhRMA, the National Infusion Center Association and the Global Colon Cancer Association. Here are four things to know: The post Court rejects PhRMA’s challenge to Medicare drug price negotiations appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.